Sus Clinicals, Inc

Sus Clinicals solves major problems in qualifying new cancer drugs, devices, diagnostics and therapies. Using a proprietary model of testing on genetically-modified pigs pioneered at the University of Illinois, Sus Clinicals leverages the inherent advantages of a patent-pending large animal testing methodology combined with novel clinical approaches to reduce false positives, model the interactions of multiple diseases, and accelerate progress toward human trials for the most promising therapies

Sus clinicals, inc operates in the Research services industry.

Sus clinicals, inc's revenue is 11m - 100m

Sus clinicals, inc has 11 - 50 employees.